Skip to content

This content is in French.

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS (ESMO) 2021

16 Septembre 2021 · 6 joursOnline, FranceOncologyEnglish
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS (ESMO) 2021
Online

About this congress

The ESMO Congress is the yearly appointment in Europe for nearly 30’000 clinicians, researchers, oncology nurses, patient advocates, journalists and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer patient care.

The ESMO 2021 programme will be developed by a committee composed of more than 300 international experts and will span from basic research to the latest discoveries in immunotherapy of cancer, form oncology nursing to palliative care, from rare cancers to approval of medicines.

Paris will be the home of the ESMO annual congress for the first time, taking place from 17 to 21 September 2021 at the Paris Expo Porte de Versailles, France.

Videos from this congress

ESMO Congress 2021: Science
Play the video · ESMO Congress 2021: ScienceFree registration required to play

00:00:30

Daniel  Catenacci · Personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC
Play the video · Daniel Catenacci · Personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLCFree registration required to play

Daniel Catenacci · 00:04:10

Daniel  Catenacci · MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEA
Play the video · Daniel Catenacci · MAHOGANY: margetuximab and retifanlimab in HER2+, 1L unresectable/metastatic GEAFree registration required to play

Daniel Catenacci · 00:04:09

Daniel  Catenacci · Gastroesophageal carcinoma with HER2 gene amplification
Play the video · Daniel Catenacci · Gastroesophageal carcinoma with HER2 gene amplificationFree registration required to play

Daniel Catenacci · 00:01:42

Isabelle Ray-Coquard · Testing HRD in the clinic
Play the video · Isabelle Ray-Coquard · Testing HRD in the clinicFree registration required to play

Isabelle Ray-Coquard · 00:01:18

Javier Garcia-Corbacho · CLIMB360: ctDNA-based molecular screening
Play the video · Javier Garcia-Corbacho · CLIMB360: ctDNA-based molecular screeningFree registration required to play

Javier Garcia-Corbacho · 00:01:32

Icro Meattini · Impact of metastases-directed radiation therapy on CDK4/6 inhibitors treatment for mBC
Play the video · Icro Meattini · Impact of metastases-directed radiation therapy on CDK4/6 inhibitors treatment for mBCFree registration required to play

Icro Meattini · 00:03:21

Roussos Torres · Combining epigenetic modulators and immune checkpoint blockade in cancer
Play the video · Roussos Torres · Combining epigenetic modulators and immune checkpoint blockade in cancerFree registration required to play

Roussos Torres · 00:03:22

Roussos Torres · Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer
Play the video · Roussos Torres · Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancerFree registration required to play

Roussos Torres · 00:04:45

Nadia Harbeck · ELEANOR: real-world use of neratinib in HER2+, early breast cancer
Play the video · Nadia Harbeck · ELEANOR: real-world use of neratinib in HER2+, early breast cancerFree registration required to play

Nadia Harbeck · 00:02:33

Nadia Harbeck · The impact of biomarkers on pCR and survival in WSG ADAPT TP
Play the video · Nadia Harbeck · The impact of biomarkers on pCR and survival in WSG ADAPT TPFree registration required to play

Nadia Harbeck · 00:04:54

Peter Schmid · BARBICAN: ipatasertib plus atezolizumab and chemotherapy in TNBC
Play the video · Peter Schmid · BARBICAN: ipatasertib plus atezolizumab and chemotherapy in TNBCFree registration required to play

Peter Schmid · 00:03:44